SEC Filing Details
Document Details
Form
Filing Date
September 23, 2022
Document Date
September 23, 2022
Form Description
A preliminary proxy statement relating to a merger or acquisition
Filing Group
Mergers & Acquisitions
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.